HYPERURICEMIA
Clinical trials for HYPERURICEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERURICEMIA trials appear
Sign up with your email to follow new studies for HYPERURICEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to tame the Gout-Causing chemical
Disease control Recruiting nowThis study is testing a new oral medication called IG3018 for people with high levels of uric acid in their blood, a condition that can lead to gout and kidney problems. Researchers want to find a safe and effective dose that can lower uric acid levels. The trial includes people …
Matched conditions: HYPERURICEMIA
Phase: PHASE1, PHASE2 • Sponsor: Intelligem Therapeutics Australia Pty Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for tough gout cases: trial tests Next-Line treatment
Disease control Recruiting nowThis study is testing a new combination of medications (AR882 with a standard drug) for people with severe, uncontrolled gout. It's specifically for those whose gout did not improve or who had bad reactions to a previous strong treatment called uricase. The main goals are to see …
Matched conditions: HYPERURICEMIA
Phase: PHASE2 • Sponsor: Arthrosi Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Can your phone prescribe exercise to fight common health risks?
Disease control Recruiting nowThis study is testing whether a smartphone app that gives personalized exercise advice can help people with common health conditions like high blood pressure or high blood sugar become more physically active. About 100 adults in China who are not currently active will use the app…
Matched conditions: HYPERURICEMIA
Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
First-in-Human trial begins for potential Gout-Preventing injection
Disease control Recruiting nowThis is the first time a new drug called NNC4004-0002 is being given to people. The study aims to see if it is safe and how well the body tolerates it in adults with high uric acid levels but no symptoms. Researchers will also check if a single injection can lower uric acid in th…
Matched conditions: HYPERURICEMIA
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC